Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease artery disease
Phenotype |diabetes mellitus
Sentences 76
PubMedID- 20347119 Introduction: type 2 diabetes mellitus (dm) patients with coronary artery disease (cad) have elevated plasma oxidized-ldl (oxldl) levels and impaired neovascularization.
PubMedID- 26244031 The everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (essence-diabetes) randomized study compared ees (n=149) and ses (n=151) implantation in diabetic patients.
PubMedID- 24282409 This review examines potential biological markers, ykl-40, alpha-hydroxybutyrate, soluble cd36, leptin, resistin, interleukin-18, retinol binding protein-4, and chemerin, as they may play significant roles in insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease.
PubMedID- 23431252 There was no statistically significant difference between the two groups in hypertension, diabetes mellitus, smoking, history of coronary artery disease, preinfarction angina, and previous history of mi (p > 0.05).
PubMedID- 22276258 Screening for coronary artery disease in patients with type 2 diabetes mellitus: an evidence-based review.
PubMedID- 24600114 Background: the mortality and morbidity rates are two to fourfold higher among coronary artery disease (cad) patients with type 2 diabetes mellitus (dm).
PubMedID- 25018979 Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
PubMedID- 24667131 Reported the coronary angiography data suggesting that small chylomicron remnants were implicated in the progression of coronary artery diseases in patients with type 2 diabetes mellitus [26].
PubMedID- 25938439 Ir plays a key role in the pathogenesis of atherosclerosis, from the initiation and progression of disease to the formation of clinically significant plaques and coronary artery disease, even in patients without diabetes mellitus [9–11].
PubMedID- 23272439 Conclusion: presence of diabetes mellitus is associated with diffuse coronary artery disease and significant carotid artery disease in patients undergoing coronary artery bypass grafting.
PubMedID- 21507365 Opposing effects of beta blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.
PubMedID- 24273550 Decreased mirna-126 was also found in atherosclerotic coronary artery disease (cad) and in patients with type 2 diabetes mellitus and may reflect the condition of vascular endothelial cells in heart failure patients (fukushima et al., 2011).
PubMedID- 22528595 Diagnosis of coronary artery disease in persons with diabetes mellitus.
PubMedID- 21063711 2segmental coronary artery disease in patients with and without diabetes mellitus.
PubMedID- 21386092 Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
PubMedID- 23230096 The study on the prognosis and effect of antidiabetic drugs on type 2 diabetes mellitus with coronary artery disease (spread-dimcad) was a prospective, randomized, double-blind, placebo-controlled trial that evaluated the different effects of glipizide and metformin on the major cardiovascular events and mortality among type 2 diabetic patients with a history of cad.
PubMedID- 22666259 Exclusion criteria were diabetes mellitus, history of coronary artery disease, congestive heart failure, congenital or acquired arrhythmia syndromes, use of drugs that lengthen the qt interval, current af, bundle branch block, atrioventricular blocks, and unmeasurable t waves (<0.15 mv) on surface ecg.
PubMedID- 22140324 Among the risk factors identified for acs in this group are hypercholesterolemia, hypertension, diabetes mellitus, family history of coronary artery disease (cad), and cigarette smoking.
PubMedID- 26342170 Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review.
PubMedID- 20591621 Methods: individuals aged < or = 65 years not taking statins and without diabetes mellitus or histories of coronary artery disease underwent cimt and plaque examination for primary prevention.
PubMedID- 24821368 Objective: the aim of this study was to examine the impact of cyp2c19 genotype on clinical outcome in coronary artery disease (cad) patients with or without diabetes mellitus (dm).
PubMedID- 22327630 Information on clinical variables (ie, dyslipidaemia, hypertension, smoking, diabetes mellitus, family history of coronary artery disease (cad), indication for pci, previous myocardial infarction (mi), previous coronary artery bypass graft surgery, previous pci, multivessel disease and left ventricular ejection fraction (lvef)) were prospectively collected at the time of the procedure and recorded in the institutional database.
PubMedID- PMC2934129 The most common single etiology was vavular heart disease, the most common triple etiology was coronary artery disease complicated with hypertension and diabetes mellitus.
PubMedID- 23153979 This study determined the role of endothelial nitric oxide synthase (enos) glu298asp polymorphism and intergenotypic variation of plasma nitric oxide (no) levels in coronary artery disease (cad) patients with type 2 diabetes mellitus (dm).
PubMedID- 26161102 In accordance with the requirement for uniform reporting standards [17], the following parameters were analyzed: age, gender, smoking habits, hypertension, dyslipidemia (defined as increased blood low-density lipoprotein (ldl) cholesterol concentration above 100 mg/dl, and/or triglyceride blood concentration above 150 mg/dl, or hypolipemic treatment on admission for a first endovascular procedure), diabetes mellitus, a history of coronary artery disease (cad), percutaneous coronary intervention (pci), a coronary artery bypass graft (cabg), congestive heart failure (chf), stroke, chronic kidney disease with a blood creatinine level of > 2 mg/dl, weight, height, body mass index (bmi), bilateral ankle-brachial index (abi), and claudication distance.
PubMedID- 22048611 The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 20519088 Clinical manifestations and risk factors of coronary artery disease in patients with diabetes mellitus in western siberia.
PubMedID- 26295080 Medical management of peripheral artery disease in diabetes mellitus.
PubMedID- 20221852 Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.
PubMedID- 24063840 Comparison of zotarolimus-eluting stent versus sirolimus-eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the essence-diabetes ii trial.
PubMedID- 25042974 [prevalence and factors associated with peripheral artery disease in patients with type 2 diabetes mellitus in primary care].
PubMedID- 23609464 Serum s100a12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 24169284 [effects of allitridi capsules on endothelial function and clinical prognosis after percutaneous coronary intervention in coronary artery disease patients with diabetes mellitus].
PubMedID- 23062567 Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating "sick fat" through improving fat function with antidiabetes therapies.
PubMedID- 25438840 Diagnostic power of longitudinal strain at rest for the detection of obstructive coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 24819198 Although revascularization through balloon dilatation or stent placemet would ameliorate coronary artery disease, patients with diabetes mellitus experienced worse outcomes than non-diabetic patients [2].
PubMedID- 20229160 [revascularization of coronary artery disease in diabetes mellitus].
PubMedID- 22868391 These guidelines recommend more aggressive control of blood pressure (bp <130/80 mm hg) among those at high risk for coronary artery disease, individuals with diabetes mellitus, chronic kidney disease, coronary artery disease or coronary artery disease risk equivalent, or a 10-year framingham risk score >/=10%.
PubMedID- 23597770 Patients with type 2 diabetes mellitus without evidence of coronary artery disease were recruited.
PubMedID- 26265234 Investigation of mda-ldl (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
PubMedID- 21810659 Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (essence-diabetes): results from the essence-diabetes trial.
PubMedID- 21034455 Background: the aim of the present cross-sectional study was to assess possible associations between osteopontin (opn), and thrombin-cleaved (n-half) opn, and nephropathy and coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm).
PubMedID- 23474620 Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus.
PubMedID- 23018602 Objectives: this study aimed to compare the value of serum glycated albumin (ga) level versus glycated hemoglobin a(1c) (hba(1c)) for evaluating the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm).
PubMedID- 23389094 We compared midterm prognostic predictors of peripheral artery disease (pad) with or without diabetes mellitus (dm) presenting with critical lower limb ischemia (cli).
PubMedID- 20225090 Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus.
PubMedID- 20376883 Preoperative risk factors for coronary artery disease included diabetes mellitus in 32 patients, hypertension in 60 patients, smoking in 63 patients, obesity in 5 patients, family history of coronary artery disease in 2 patients, and hypercholesterolemia in 33 patients (table 2).
PubMedID- 23184484 Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.
PubMedID- 21349201 The objective of this study was to assess the relationship between glycemic variability determined by a continuous glucose monitoring (cgm) system and the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm).
PubMedID- 21200101 Results: the two groups were similar with regard to age, gender, hypertension, diabetes mellitus, family history of coronary artery disease, smoking, and alcohol consumption.

Page: 1 2